EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas.

MLA

Dongsheng Yue, et al. “EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas.” PLoS ONE, vol. 10, no. 7, Jan. 2015, p. e0132134. EBSCOhost, https://doi.org/10.1371/journal.pone.0132134.

APA

Dongsheng Yue, Hui Li, Juanjuan Che, Yi Zhang, Bhairavi Tolani, Minli Mo, Hua Zhang, Qingfeng Zheng, Yue Yang, Runfen Cheng, Joy Q Jin, Thomas W Luh, Cathryn Yang, Hsin-Hui K Tseng, Etienne Giroux-Leprieur, Gavitt A Woodard, Xishan Hao, Changli Wang, David M Jablons, & Biao He. (2015). EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas. PLoS ONE, 10(7), e0132134. https://doi.org/10.1371/journal.pone.0132134

Chicago

Dongsheng Yue, Hui Li, Juanjuan Che, Yi Zhang, Bhairavi Tolani, Minli Mo, Hua Zhang, et al. 2015. “EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas.” PLoS ONE 10 (7): e0132134. doi:10.1371/journal.pone.0132134.